< Back to latest news & events

Articles

Comparing the value of European vs Unitary Patent Validation

November 2022

The EPO’s European patent system is on the brink of the biggest change in a generation – from 2023 it is expected that a new unitary patent (UP) will become available via the EPO.

The new Unitary Patent

Requesting a UP will create a single patent with unitary effect across all of the EU Member States (EU MS) that have ratified the UPC Agreement. Based on current ratifications, at launch the initial UP’s coverage will include at least 17 EU MS, including Germany, France, Italy and the Netherlands.

For future UPs, if all participating EU MS ratify the UPCA, the UP will cover 24 EU MS. But initially, the UP will cover the territories of countries that have ratified the UPC Agreement at the date of the registration of the unitary effect of the individual patent. Coverage of a UP will remain fixed throughout its lifetime and will not be extended to EU MS that join the UPC at a later date. The UP is subject entirely to the exclusive jurisdiction of the new UPC.

Costs vs coverage

Renewal fees for a UP will be payable to the EPO in Euros. The EPO has set the renewal fees to be equivalent to the combined renewal fees that would be payable in the four countries where EPs were most often validated in 2015. Although the UP will be significantly more cost-effective than a widely-validated classical EP, because the UP is a unitary right, it is not possible to reduce the annual renewal fees by tapering the R-MS territories during the lifetime of the patent.

It is important to remember that, in order to obtain coverage in other EPC countries outside the UP at the time, patentees will still need to validate nationally in those EPC states.
So, will the UP be able to provide better value for patentees? Well, that depends!

In terms of validation costs relative to the population and GDP of the separate initial 17 UP EU MS, the UP presents excellent value as shown below. But in order to obtain coverage in other EPC countries outside the UP EU MS at the time, patentees will still need to validate nationally in those EPC states, which will be an additional cost on top of the UP itself.

In terms of lifetime costs, the chart below shows the relative cumulative costs of an EP patent granted at year 6 (validation costs + renewal costs at year 6) and then the subsequent renewal costs from year 7 onwards, including official and professional fees. Assuming the patent was granted in year 6, validation and renewal costs become payable on grant. Depending on where the EP patent is validated, the cumulative costs will vary. A UP represents a substantial cost saving over the lifetime of the patent compared to separately validated EPs in 4 or more UP countries, however, it is important to remember that as a unitary right, a UP patent must be renewed as a whole, whereas EP patents validated may be renewed, or not, separately.

These figures have been shown as a guide for a specification filed in English having 15 claims.

If you would like to look at the relative costs of an EP that is close to grant, HGF can provide a detailed cost estimate for your own EP vs UP validation strategy – please contact our UPC ready team – upcready@hgf.com or your usual HGF representative.


This update was prepared by HGF Partner & Patent Attorney Andrew Camenisch.

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article